Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Corcept Therapeutics ROE 2010-2025 | CORT

Current and historical return on equity (ROE) values for Corcept Therapeutics (CORT) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
  
Corcept Therapeutics ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $0.13B $0.68B 20.32%
2024-12-31 $0.14B $0.68B 22.74%
2024-09-30 $0.14B $0.64B 24.63%
2024-06-30 $0.13B $0.60B 23.66%
2024-03-31 $0.12B $0.55B 24.14%
2023-12-31 $0.11B $0.51B 21.86%
2023-09-30 $0.09B $0.46B 18.79%
2023-06-30 $0.09B $0.42B 19.51%
2023-03-31 $0.09B $0.53B 19.31%
2022-12-31 $0.10B $0.50B 22.14%
2022-09-30 $0.12B $0.47B 27.55%
2022-06-30 $0.11B $0.44B 25.37%
2022-03-31 $0.11B $0.41B 24.26%
2021-12-31 $0.11B $0.38B 22.97%
2021-09-30 $0.11B $0.54B 20.22%
2021-06-30 $0.10B $0.52B 19.15%
2021-03-31 $0.10B $0.51B 20.02%
2020-12-31 $0.11B $0.52B 22.60%
2020-09-30 $0.11B $0.49B 25.29%
2020-06-30 $0.11B $0.45B 28.83%
2020-03-31 $0.11B $0.41B 29.75%
2019-12-31 $0.09B $0.37B 28.86%
2019-09-30 $0.09B $0.33B 28.81%
2019-06-30 $0.08B $0.30B 27.86%
2019-03-31 $0.08B $0.29B 28.52%
2018-12-31 $0.08B $0.28B 30.15%
2018-09-30 $0.15B $0.26B 66.37%
2018-06-30 $0.15B $0.24B 79.89%
2018-03-31 $0.14B $0.22B 101.79%
2017-12-31 $0.13B $0.19B 131.30%
2017-09-30 $0.04B $0.09B 59.26%
2017-06-30 $0.03B $0.07B 53.19%
2017-03-31 $0.01B $0.05B 35.14%
2016-12-31 $0.01B $0.04B 30.51%
2016-09-30 $0.01B $0.03B 21.05%
2016-06-30 $0.00B $0.03B 5.19%
2016-03-31 $0.00B $0.02B -12.70%
2015-12-31 $-0.01B $0.02B -51.85%
2015-09-30 $-0.01B $0.01B -145.45%
2015-06-30 $-0.02B $0.01B -357.89%
2015-03-31 $-0.02B $0.01B -920.00%
2014-12-31 $-0.03B $0.00B -1600.00%
2014-09-30 $-0.04B $0.00B -487.50%
2014-06-30 $-0.04B $0.00B -275.00%
2014-03-31 $-0.05B $0.01B -190.10%
2013-12-31 $-0.05B $0.02B -128.67%
2013-09-30 $-0.05B $0.03B -100.00%
2013-06-30 $-0.04B $0.04B -76.44%
2013-03-31 $-0.04B $0.05B -71.56%
2012-12-31 $-0.04B $0.06B -73.79%
2012-09-30 $-0.04B $0.07B -82.68%
2012-06-30 $-0.04B $0.03B -92.72%
2012-03-31 $-0.04B $0.04B -86.23%
2011-12-31 $-0.03B $0.04B -69.19%
2011-09-30 $-0.03B $0.04B -67.84%
2011-06-30 $-0.03B $0.05B -77.92%
2011-03-31 $-0.03B $0.06B -78.26%
2010-12-31 $-0.03B $0.02B -106.12%
2010-09-30 $-0.02B $0.03B -96.97%
2010-06-30 $-0.02B $0.03B -108.64%
2010-03-31 $-0.02B $0.02B -137.70%
2009-12-31 $-0.02B $0.02B -129.03%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $7.765B $0.675B
Corcept is focused on the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncology disorders which are associated with the activity of the hormone cortisol, also known as the stress hormone. Corcept's only marketed drug, Korlym (mifepristone), is approved for the once-daily oral treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, suffering from type II diabetes or glucose intolerance and who have failed surgery or are not suitable for surgery.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $86.719B 32.53
Zoetis (ZTS) United States $69.528B 25.94
Takeda Pharmaceutical (TAK) Japan $48.047B 9.56
Daiichi Sankyo, - (DSNKY) Japan $43.343B 22.21
BeOne Medicines - (ONC) Cayman Islands $26.436B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.802B 0.00
Merck (MKKGY) Germany $17.015B 12.47
Summit Therapeutics (SMMT) United States $15.299B 0.00
Shionogi (SGIOY) Japan $14.887B 0.00
United Therapeutics (UTHR) United States $12.822B 11.34
Neurocrine Biosciences (NBIX) United States $12.412B 42.51
Orion OYJ (ORINY) Finland $10.495B 28.38
IPSEN (IPSEY) France $9.739B 0.00
Stevanato Group S.p.A (STVN) Italy $7.462B 45.63
Madrigal Pharmaceuticals (MDGL) United States $6.678B 0.00
Ionis Pharmaceuticals (IONS) United States $6.335B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $6.092B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Soleno Therapeutics (SLNO) United States $4.195B 0.00
Hypermarcas (HYPMY) Brazil $3.072B 20.21
Crinetics Pharmaceuticals (CRNX) United States $2.805B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.657B 9.31
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.548B 13.78
NewAmsterdam Pharma (NAMS) Netherlands $2.085B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.959B 0.00
Indivior (INDV) United States $1.923B 8.16
ARS Pharmaceuticals (SPRY) United States $1.787B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.754B 0.00
Endo (NDOI) United States $1.603B 0.00
Evotec AG (EVO) Germany $1.477B 0.00
Ocular Therapeutix (OCUL) United States $1.469B 0.00
Guardian Pharmacy Services (GRDN) United States $1.353B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.167B 23.35
Harrow (HROW) United States $1.133B 0.00
Dyne Therapeutics (DYN) United States $1.088B 0.00
Enliven Therapeutics (ELVN) United States $1.015B 0.00
Verve Therapeutics (VERV) United States $1.007B 0.00
Collegium Pharmaceutical (COLL) United States $0.962B 5.19
Akebia Therapeutics (AKBA) United States $0.959B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.890B 0.00
Ardelyx (ARDX) United States $0.883B 0.00
Elite Pharmaceuticals (ELTP) United States $0.760B 0.00
Xeris Biopharma Holdings (XERS) United States $0.735B 0.00
Cronos Group (CRON) Canada $0.733B 0.00
USANA Health Sciences (USNA) United States $0.580B 12.60
Xencor (XNCR) United States $0.579B 0.00
KalVista Pharmaceuticals (KALV) United States $0.567B 0.00
Relay Therapeutics (RLAY) United States $0.566B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.564B 0.00
Theravance Biopharma (TBPH) United States $0.561B 0.00
Bioventus (BVS) United States $0.556B 14.10
Zevra Therapeutics (ZVRA) United States $0.492B 0.00
AleAnna (ANNA) United States $0.481B 0.00
Organogenesis (ORGO) United States $0.466B 0.00
Siga Technologies (SIGA) United States $0.462B 9.64
Tourmaline Bio (TRML) United States $0.425B 0.00
Oruka Therapeutics (ORKA) United States $0.415B 0.00
Savara (SVRA) United States $0.382B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.348B 9.41
Heron Therapeutics (HRTX) United States $0.326B 0.00
Aquestive Therapeutics (AQST) United States $0.323B 0.00
Nektar Therapeutics (NKTR) United States $0.320B 0.00
Altimmune (ALT) United States $0.284B 0.00
Nature's Sunshine Products (NATR) United States $0.268B 24.58
Tonix Pharmaceuticals Holding (TNXP) United States $0.257B 0.00
Liminatus Pharma (LIMN) United States $0.247B 0.00
Aldeyra Therapeutics (ALDX) United States $0.227B 0.00
Nanobiotix S.A (NBTX) France $0.213B 0.00
MediWound (MDWD) Israel $0.208B 0.00
OmniAb (OABI) United States $0.208B 0.00
Esperion Therapeutics (ESPR) United States $0.197B 0.00
ProKidney (PROK) United States $0.196B 0.00
Larimar Therapeutics (LRMR) United States $0.194B 0.00
Profound Medical (PROF) Canada $0.180B 0.00
4D Molecular Therapeutics (FDMT) United States $0.178B 0.00
Journey Medical (DERM) United States $0.166B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Aclaris Therapeutics (ACRS) United States $0.159B 0.00
Galectin Therapeutics (GALT) United States $0.147B 0.00
Avita Medical (RCEL) United States $0.144B 0.00
Lexeo Therapeutics (LXEO) United States $0.137B 0.00
Lyell Immunopharma (LYEL) United States $0.132B 0.00
Inhibikase Therapeutics (IKT) United States $0.120B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.118B 0.00
Cardiol Therapeutics (CRDL) Canada $0.117B 0.00
Korro Bio (KRRO) United States $0.113B 0.00
VAXART, INC (VXRT) United States $0.113B 0.00
Protara Therapeutics (TARA) United States $0.111B 0.00
Champions Oncology (CSBR) United States $0.107B 17.64
Corbus Pharmaceuticals Holdings (CRBP) United States $0.091B 0.00
Arch Biopartners (ACHFF) Canada $0.090B 0.00
Nutriband (NTRB) United States $0.089B 0.00
Unicycive Therapeutics (UNCY) United States $0.086B 0.00
Cassava Sciences (SAVA) United States $0.085B 0.00
Dominari Holdings (DOMH) United States $0.081B 0.00
Fractyl Health (GUTS) United States $0.080B 0.00
Vivani Medical (VANI) United States $0.078B 0.00
Achieve Life Sciences (ACHV) Canada $0.077B 0.00
Surrozen (SRZN) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Wellgistics Health (WGRX) United States $0.073B 0.00
Pyxis Oncology (PYXS) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.062B 0.00
Context Therapeutics (CNTX) United States $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.059B 0.00
Gain Therapeutics (GANX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Inotiv (NOTV) United States $0.058B 0.00
Rafael Holdings (RFL) United States $0.058B 0.00
PMV Pharmaceuticals (PMVP) United States $0.056B 0.00
Metagenomi (MGX) United States $0.055B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.048B 0.00
Telomir Pharmaceuticals (TELO) United States $0.046B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
Prelude Therapeutics (PRLD) United States $0.044B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.039B 28.89
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
Acrivon Therapeutics (ACRV) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Jupiter Neurosciences (JUNS) United States $0.035B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
China SXT Pharmaceuticals (SXTC) China $0.027B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Klotho Neurosciences (KLTO) United States $0.023B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
FibroGen (FGEN) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
DURECT (DRRX) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.016B 0.00
Plus Therapeutics (PSTV) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
CASI Pharmaceuticals (CASI) China $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.17
Cosmos Health (COSM) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Ainos (AIMD) United States $0.010B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00